ResearcherFirst Hospital of Jilin UniversityNo recent work listed

Shiquan Li

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-3744-2737; OpenAlex author ID A5052104343. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 3

Papers, trials and grants by year

2019: 1 paper · 2020: none · 2021: 1 paper

Papers 2

Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microRNA-15a-5p/FGFR1 axis. Co-author DOI 10.18632/aging.202540 ↗
MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS1. Co-author DOI 10.3892/mmr.2018.9770 ↗

Closest collaborators

The 3 strongest of 3 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Zhennan Yun · 1 shared paper, 2021 · strength 0.19
- Paper Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microR… DOI 10.18632/aging.202540 ↗
Ping Zhang · 1 shared paper, 2021 · strength 0.19
- Paper Long non-coding RNA CERS6-AS1 facilitates the oncogenicity of pancreatic ductal adenocarcinoma by regulating the microR… DOI 10.18632/aging.202540 ↗
Lei Wang · 1 shared paper, 2019 · strength 0.12
- Paper MicroRNA‑766 inhibits the malignant biological behaviours of pancreatic ductal adenocarcinoma by directly targeting ETS… DOI 10.3892/mmr.2018.9770 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.